Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
CBHB(09668) opens a new chapter in the first quarter: total assets exceed 2 trillion for the first time, risk control upgrades to safeguard high-quality development.
Aerospace equipment manufacturer Applied Aerospace & Defense (AADX.US) applies for a US stock IPO, planning to raise $350 million.
Beijing Beilu Pharmaceutical (300016.SZ) has obtained the "Drug Registration Certificate" for Iodinated Phochol Injection.
CBHB(09668) opens a new chapter in the first quarter: total assets exceed 2 trillion for the first time, risk control upgrades to safeguard high-quality development.
Aerospace equipment manufacturer Applied Aerospace & Defense (AADX.US) applies for a US stock IPO, planning to raise $350 million.
Beijing Beilu Pharmaceutical (300016.SZ) has obtained the "Drug Registration Certificate" for Iodinated Phochol Injection.
